Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.71B | 2.94B | 3.53B | 3.43B | 3.83B |
Gross Profit | 1.91B | 2.11B | 2.42B | 2.14B | 2.73B |
EBITDA | 242.60M | -33.16M | 185.13M | 255.05M | 152.80M |
Net Income | 160.31M | -384.61M | 40.38M | -23.23M | 45.91M |
Balance Sheet | |||||
Total Assets | 3.57B | 3.85B | 4.35B | 4.72B | 5.00B |
Cash, Cash Equivalents and Short-Term Investments | 208.73M | 247.67M | 129.38M | 113.43M | 44.74M |
Total Debt | 451.69M | 1.05B | 1.18B | 1.79B | 2.49B |
Total Liabilities | 1.33B | 1.87B | 2.09B | 3.20B | 3.49B |
Stockholders Equity | 2.24B | 1.98B | 2.27B | 1.51B | 1.50B |
Cash Flow | |||||
Free Cash Flow | 408.70M | 243.33M | -160.58M | 374.53M | 14.73M |
Operating Cash Flow | 453.06M | 278.59M | -107.06M | 427.02M | 34.93M |
Investing Cash Flow | 7.30M | -29.30M | 63.30M | 330.37M | 23.66M |
Financing Cash Flow | -499.31M | -131.00M | 59.71M | -693.39M | -873.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥40.90B | 28.60 | 1.40% | 6.10% | 13.84% | ||
68 Neutral | ¥221.32B | 22.43 | 8.23% | 2.16% | 4.86% | -0.08% | |
68 Neutral | ¥1.63B | 4.86 | ― | 8.96% | ― | ||
64 Neutral | $63.02B | 31.28 | 3.06% | 2.86% | 5.55% | -14.52% | |
63 Neutral | ¥6.47B | 10.12 | 2.35% | -2.13% | ― | ||
55 Neutral | ¥6.09B | 157.89 | 1.57% | -9.81% | ― | ||
45 Neutral | ¥5.10B | 20.23 | 1.68% | 7.21% | ― |
Ivy Cosmetics Corporation reported a significant decline in its financial performance for the first quarter ending June 2025. The company experienced a 15.7% decrease in net sales compared to the previous year, alongside operating and ordinary losses. Despite these challenges, the capital adequacy ratio improved to 74.9%, indicating a strong equity position. The company did not declare any dividends for the quarter, reflecting its focus on stabilizing operations amidst financial setbacks.
Ivy Cosmetics Corporation reported a significant increase in operating and ordinary profits for the fiscal year ending March 2025, with operating profit rising by 125.9% and ordinary profit by 124.2%. Despite a decline in net profit by 73.2%, the company improved its capital adequacy ratio to 69.2%, indicating a stronger financial position, which may positively impact its market standing and stakeholder confidence.